Biogen (BIIB) option implied volatility movement into data

Biogen (NASDAQ: BIIB) September weekly option implied volatility is at 225, October is at 110; compared to its 52-week range 29 to 97 into topline phase 3 data for Alzheimer's drug lecanemab.

You May Also Be Interested In

• Uniti Group (UNIT) 3700 contracts of July 13 calls trade, share up 7%
• L3Harris Technologies (LHX) call put ratio 3.5 calls to 1 put as share price up 3.9%
• Oxford Industries (OXM) call put ratio 1 call to 5.8 puts to 1 put with a focus on June 30 puts